Abstract
We report a case of specific myocardiotoxicity due to 5 F.U. not previously described in man. A 41-year-old man was admitted to the ICU for heart and renal failure, appearing 24 h after 5 days treatment with 5 F.U. and cis-platinum. Dopamine was necessary to maintain blood pressure. Two-D echocardiography and a right heart catheterisation confirmed the alteration of myocardial contractility. After 2 weeks a complete cardiac recovery occurred.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Labianca R, Beretta G, Clerici M, Freschini P, Luporini G (1982) Cardiac Toxicity of 5 F.U.: a study on 1083 patients. Tumori 68:505
Pottage A, Holt S, Ludgate S, Langlands AO (1978) Fluorouracil cardiotoxicity. Br Med J 1:547
Johnson RA, Palacios I (1982) Dilated Cardiomyopathy of the Adult. N Engl J Med 307:1051 and 1119
Goodwin JF, Roberts WC, Wenger NK (1982) Myocardiopathy. In: Hurst JW (ed) The heart. McGraw Hill, New York
Levillain R (1972) Myocardite experimentale: étude anatomique de 210 coeurs de rats inférés au 5 Fluorouracile. CR Acad Sci 166:340
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coronel, B., Madonna, O., Mercatello, A. et al. Myocardiotoxicity of 5 Fluorouracil. Intensive Care Med 14, 429–430 (1988). https://doi.org/10.1007/BF00262901
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00262901